| Autor: |
He SF; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China.; Department of Pharmacy, Dongguan People's Hospital, Dongguan, 523059, China., Pan NL; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Chen BB; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Liao JX; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Huang MY; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Qiu HJ; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Jiang DC; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Wang JJ; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China., Chen JX; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China. cppcc@qq.com., Sun J; School of Pharmacy, Guangdong Medical University, Dongguan, 523808, China. sunjing@gdmu.edu.cn. |
| Abstrakt: |
As the "powerhouse" of a cell, mitochondria maintain energy homeostasis, synthesize ATP via oxidative phosphorylation, generate ROS signaling molecules, and modulate cell apoptosis. Herein, three Re(I) complexes bearing guanidinium derivatives have been synthesized and characterized. All of these complexes exhibit moderate anticancer activity in HepG2, HeLa, MCF-7, and A549 cancer cells. Mechanism studies indicate that complex 3, [Re(CO)3(L)(Im)](PF 6 ) 2 , can selectively localize in the mitochondria and induce cancer cell death through mitochondria-associated pathways. In addition, complex 3 can effectively depress the ability of cell migration, cell invasion, and colony formation. |
